3,941 Shares in The Clorox Company $CLX Acquired by Caxton Associates LLP

Key Points

• Caxton Associates LLP acquired a new position in The Clorox Company, purchasing 3,941 shares valued at approximately $580,000 during the 1st quarter of 2023.
• Clorox's recent earnings reported $2.87 EPS, surpassing estimates, with a revenue increase of 4.5% year-over-year, leading to a positive outlook for fiscal year 2026.
• The company announced a quarterly dividend of $1.24, representing a 4.0% yield, reflecting a slight increase from the previous $1.22 dividend.

Caxton Associates LLP purchased a new position in The Clorox Company (NYSE:CLX - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 3,941 shares of the company's stock, valued at approximately $580,000.

Several other hedge funds have also made changes to their positions in CLX. Wood Tarver Financial Group LLC acquired a new stake in Clorox in the 4th quarter valued at approximately $31,000. GW&K Investment Management LLC increased its position in Clorox by 239.1% in the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock valued at $43,000 after acquiring an additional 208 shares during the period. Roble Belko & Company Inc increased its position in Clorox by 140.7% in the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after acquiring an additional 211 shares during the period. Menard Financial Group LLC acquired a new stake in Clorox in the 4th quarter valued at approximately $63,000. Finally, IMA Advisory Services Inc. acquired a new stake in Clorox in the 1st quarter valued at approximately $58,000. Institutional investors own 78.53% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Wells Fargo & Company lowered their target price on Clorox from $138.00 to $130.00 and set an "equal weight" rating on the stock in a research report on Friday, September 5th. UBS Group lowered their target price on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a research report on Thursday, July 17th. JPMorgan Chase & Co. raised their target price on Clorox from $133.00 to $135.00 and gave the company a "neutral" rating in a research report on Monday. Barclays lowered their price target on Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a research report on Tuesday, July 15th. Finally, Jefferies Financial Group lowered their price target on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research report on Thursday, June 26th. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Reduce" and an average price target of $142.18.

Clorox Stock Performance

Shares of NYSE CLX opened at $124.44 on Friday. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The stock has a market capitalization of $15.22 billion, a price-to-earnings ratio of 19.09, a PEG ratio of 0.99 and a beta of 0.52. The stock's fifty day simple moving average is $124.30 and its 200 day simple moving average is $132.67. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. The business had revenue of $1.99 billion for the quarter, compared to analysts' expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company's quarterly revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Wednesday, August 13th were issued a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. The ex-dividend date was Wednesday, August 13th. This is a positive change from Clorox's previous quarterly dividend of $1.22. Clorox's payout ratio is presently 76.07%.

Insider Activity

In related news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. The trade was a 21.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.57% of the stock is owned by insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.